Product

Portfolio Intelligence Portside Congress trades Super-investors Economic calendar Earnings calendar Pricing

Company

About FAQs Contact Create account

Legal

Privacy Terms Portside rules

SNY

Sanofi

ADR · NASDAQ

Price and daily changeSign in

Earnings30 Oct 2026

52-week rangeSign inDay rangeSign in

Market cap

Loading evidence for SNY

Volume

Beta

Shares float

Short interest

0.34%

P/E (fwd)

PEG (fwd)

Rev growth (fwd)

Price chart (1D to 10Y)

Licensed market data — shown to members, not published to the open web.

Create free account

Overview Statistics Statements Dividends🔒Momentum🔒Quant🔒Fair Value🔒Earnings Analysts🔒Insiders Smart Money Options🔒Insights🔒

Trading information

Beta: Sign in
Shares outstandingAs of 2025-12-31 · listed ADS: 2.43B
Shares float: Sign in
Float %: Sign in
Insider ownership: —
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 0.34%
Short ratioDays to cover, as published by FINRA: 4.03
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 14.30%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 28.30%
Avg volume (10D)

See the full stock page

Prices, charts, ranges, valuation ratios, dividends, momentum and analyst estimates are licensed for signed-in members. A free account opens every stock, fund and crypto page.

Create free account

Source: SEC filings. Information and analytics, not investment advice.

Avg volume (3 months)

Profitability

Gross marginFY Dec 25: 77.17%
Operating marginFY Dec 25: 14.54%
Net margin: —
EBITDA margin: —
Return on equityNet income (FY Dec 25) ÷ average shareholders equity: 10.50%
Return on assetsNet income (FY Dec 25) ÷ average total assets: 6.02%

Growth

Revenue growth (annual YoY): 6.20%
Revenue growth (latest qtr YoY): —
Revenue growth (fwd): Sign in
Net income growth (annual YoY)FY Dec 25 vs FY Dec 24: 40.52%
Net income growth (latest qtr YoY): —
EPS growth (fwd): Sign in
Net income growth (QoQ): —

Valuation

Market cap: Sign in
Enterprise value: Sign in
P/E: Sign in
P/E (fwd): Sign in
PEG: Sign in
PEG (fwd): Sign in
Price / book: Sign in
Price / sales

Price / operating cash flow

P/FCF

EV / revenue

EV / EBITDA

EPSDiluted, FY Dec 25

6.37

EPS (fwd)

Financial health

Cash & equivalentsas of Dec 25: EUR 7.65B
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Dec 25: EUR 20.44B
Debt / equityas of Dec 25: 28.64%
Current ratioas of Dec 25: 1.09
Quick ratio: —
Operating cash flowFY Dec 25: EUR 10.75B
Free cash flow: —
TTM revenue / diluted shareDiluted, FY Dec 25: 35.60

SNY stock Statistics — Sanofi filings, insiders & smart money · Instaport